Biallelic loss of function (LOF) mutations in RIPK1 cause severe immunodeficiency in humans, characterised by impaired T- and B-lymphocyte differentiation, lymphocytopenia and diminished production of interleukin (IL)−6, tumour necrosis factor (TNF) and IL-12. The gene discussed is RIPK1; the disease is immune system disorder.